Altimmune (ALT) Depreciation Expense (2016 - 2017)
Historic Depreciation Expense for Altimmune (ALT) over the last 6 years, with Q1 2017 value amounting to $33007.0.
- Altimmune's Depreciation Expense fell 1245.06% to $33007.0 in Q1 2017 from the same period last year, while for Mar 2017 it was $138743.0, marking a year-over-year decrease of 243.04%. This contributed to the annual value of $143437.0 for FY2016, which is 129.45% up from last year.
- Latest data reveals that Altimmune reported Depreciation Expense of $33007.0 as of Q1 2017, which was down 1245.06% from $33066.0 recorded in Q4 2016.
- In the past 5 years, Altimmune's Depreciation Expense ranged from a high of $52602.0 in Q1 2013 and a low of $32235.0 during Q3 2016
- Over the past 5 years, Altimmune's median Depreciation Expense value was $37106.0 (recorded in 2015), while the average stood at $38264.3.
- As far as peak fluctuations go, Altimmune's Depreciation Expense crashed by 3845.25% in 2013, and later skyrocketed by 1021.62% in 2016.
- Over the past 5 years, Altimmune's Depreciation Expense (Quarter) stood at $43438.0 in 2013, then decreased by 15.54% to $36686.0 in 2014, then fell by 10.58% to $32806.0 in 2015, then increased by 0.79% to $33066.0 in 2016, then decreased by 0.18% to $33007.0 in 2017.
- Its last three reported values are $33007.0 in Q1 2017, $33066.0 for Q4 2016, and $32235.0 during Q3 2016.